NYSE · USNA

USANA Health Sciences Inc.

$21.32 +$0.40 (+1.91%) 1D After hours
Session Pulse After hours 7 mentions today No new SEC filings since Mon close its sector ranked 6/11 this week Full pulse →

Key Metrics

$386.25M
Market cap
43.53×
P/E · TTM
$925.94M
Revenue · TTM
$8.87M
Net income
EPS · TTM $0.46
Dividend yield
Free cash flow $2.96M
Beta · 1Y 1.25
EBITDA · TTM $72.75M
Gross margin 77.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    7 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 7, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 11
    The stock moved -8.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11
  • Feb 19
    The stock moved +8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$386.25M
Enterprise value
Shares outstanding18.5M
52-wk range$16.60 – $32.32
Avg volume · 20D102.0K
Net cash
Book value / share$28.48
IndustryMedicinal Chemicals & Botanical Products
ExchangeNYSE
About USANA Health Sciences Inc.
IPO dateApr 22, 1993
Employees1570

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E43.53
P/S0.42
P/FCF130.44
EV/EBITDA
EV/Sales
Graham №$17.26

Profitability

Gross 77.6%
Operating 4.3%
Net 1.0%
FCF 0.3%
ROE / ROIC 1.6% · 2.4%

Financial Health

Current ratio2.51
Quick ratio1.69
Debt / equity
Debt / EBITDA
Net cash
Working capital$176.99M

Cash Flow · TTM

Operating CF $16.63M
Capex −$13.67M
Free cash flow $2.96M
Buybacks $15.21M
Dividends paid
Shareholder yield 3.9%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

4.2
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$17.26 vs $21.32
Trades 1.2× above classic defensive value — priced for growth
Fundamentals through 2026-04-04 · computed by TickerWolf from SEC filings